Antiviral and Antibacterial: Focus on Novel Therapeutic Agents and Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 20 August 2024 | Viewed by 1006
Special Issue Editor
Interests: medicinal chemistry; drug discovery and development; antimycobacterial agents; antiviral agents; tuberculosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Innovative therapies against bacterial and viral diseases are an urgent need. The lack of a strong pipeline of anti-infective drugs and the increase of bacterial and viral resistance have caused a worldwide health crisis over the last decade, with well-known infectious diseases, such as AIDS and tuberculosis, still affecting millions of people worldwide. Moreover, three years of COVID-19 pandemic has taught us that also new and emerging pathogens can pose a serious threat to countries’ global health systems, demanding novel approaches in infectious disease drug development.
The aim of this Special Issue is to summarize recent research in the field of antiviral and antibacterial agents, covering all the stages and the aspects of novel candidates for infectious disease treatment, including biopharmaceuticals and innovative delivery protocols of both existing and novel antibacterials and antivirals. Potential topics to be covered include, but are not limited to:
- Discovery and Development of novel and effective antibacterial and antiviral agents;
- Innovative drug delivery systems for infectious diseases;
- Repurposing drugs to treat these infections;
- Innovative strategies to overcome drug resistance;
- Host-targeted therapies.
Dr. Sara Consalvi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medicinal chemistry
- antibacterials
- antivirals
- drug development
- drug resistance
- drug delivery
- drug candidates
- drug repurposing
